Oxnard GR, et al.:Association Between Plasma Genotyping and Outcomes of Treatment With Osimertinib(AZD9291)in Advanced Non-Small-Cell Lung Cancer. J Clin Oncol 34:3375-3382, 2016
Tan DS, et al.:The International Association for the Study of Lung Cancer Consensus Statement on Optimizing Management of EGFR Mutation-Positive Non-Small Cell Lung Cancer: Status in 2016. J Thorac Oncol 11:946-963, 2016